Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra D Laufer

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
RNA Biology|June 6, 2012
MicroRNA-mediated regulation of gene expression is affected by disease-associated SNPs within the 3'-UTR via altered RNA structureUlrike Haas, Georg Sczakiel, Sandra D Laufer
International Journal of Molecular Sciences|March 28, 2009
Recent developments in peptide-based nucleic acid deliverySandra Veldhoen, Sandra D Laufer, Tobias Restle
Nucleic Acids Research|December 1, 2006
Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effectSandra Veldhoen, Sandra D Laufer, Alexander Trampe, et al.
Oligonucleotides|February 7, 2009
Noncovalent peptide-mediated delivery of chemically modified steric block oligonucleotides promotes splice correction: quantitative analysis of uptake and biological effectSandra D Laufer, Anna Lena Recke, Sandra Veldhoen, et al.
Nucleic Acids Research|October 14, 2006
Specific binding of a hexanucleotide to HIV-1 reverse transcriptase: a novel class of bioactive moleculesAlessandra Mescalchin, Winfried Wünsche, Sandra D Laufer, et al.
Stem Cell Research|May 22, 2024
Generation of a patient-specific hiPS cell line with heterozygous GNB2 mutation (UKMi003-A) causative for human sinus node dysfunction and a corresponding CRISPR/Cas9-corrected isogenic control (UKMi004-A)Anne Kayser, Sven Dittmann, Jassin Hamidi, et al.
Chembiochem : a European Journal of Chemical Biology|March 5, 2008
Small molecule inhibitors targeting HIV-1 reverse transcriptase dimerizationDina Grohmann, Valentina Corradi, Mira Elbasyouny, et al.
Nucleic Acids Research|November 19, 2015
RNAi revised--target mRNA-dependent enhancement of gene silencingSimon Dornseifer, Sarah Willkomm, Rosel Kretschmer-Kazemi Far, et al.
Chemistry & Biology|July 28, 2007
Aptamer displacement identifies alternative small-molecule target sites that escape viral resistanceSatoko Yamazaki, Lu Tan, Günter Mayer, et al.
Molecular Therapy. Nucleic Acids|June 19, 2017
Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived CardiomyocytesMaksymilian Prondzynski, Elisabeth Krämer, Sandra D Laufer, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
RNA Biology|June 6, 2012
MicroRNA-mediated regulation of gene expression is affected by disease-associated SNPs within the 3'-UTR via altered RNA structureUlrike Haas, Georg Sczakiel, Sandra D Laufer
International Journal of Molecular Sciences|March 28, 2009
Recent developments in peptide-based nucleic acid deliverySandra Veldhoen, Sandra D Laufer, Tobias Restle
Nucleic Acids Research|December 1, 2006
Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effectSandra Veldhoen, Sandra D Laufer, Alexander Trampe, et al.
Oligonucleotides|February 7, 2009
Noncovalent peptide-mediated delivery of chemically modified steric block oligonucleotides promotes splice correction: quantitative analysis of uptake and biological effectSandra D Laufer, Anna Lena Recke, Sandra Veldhoen, et al.
Nucleic Acids Research|October 14, 2006
Specific binding of a hexanucleotide to HIV-1 reverse transcriptase: a novel class of bioactive moleculesAlessandra Mescalchin, Winfried Wünsche, Sandra D Laufer, et al.
Stem Cell Research|May 22, 2024
Generation of a patient-specific hiPS cell line with heterozygous GNB2 mutation (UKMi003-A) causative for human sinus node dysfunction and a corresponding CRISPR/Cas9-corrected isogenic control (UKMi004-A)Anne Kayser, Sven Dittmann, Jassin Hamidi, et al.
Chembiochem : a European Journal of Chemical Biology|March 5, 2008
Small molecule inhibitors targeting HIV-1 reverse transcriptase dimerizationDina Grohmann, Valentina Corradi, Mira Elbasyouny, et al.
Nucleic Acids Research|November 19, 2015
RNAi revised--target mRNA-dependent enhancement of gene silencingSimon Dornseifer, Sarah Willkomm, Rosel Kretschmer-Kazemi Far, et al.
Chemistry & Biology|July 28, 2007
Aptamer displacement identifies alternative small-molecule target sites that escape viral resistanceSatoko Yamazaki, Lu Tan, Günter Mayer, et al.
Molecular Therapy. Nucleic Acids|June 19, 2017
Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived CardiomyocytesMaksymilian Prondzynski, Elisabeth Krämer, Sandra D Laufer, et al.
Pageof 3